RYALI SRIRAM (Chief Financial Officer) sold 5.2% of their position (2.27K shares) of EIGER BIOPHARMACEUTICALS, INC. on the open market
Open‑market sale worth $12.7K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/14/2022ACC: 0001567619-22-006948
Officer· Chief Financial Officer
Since Dec 2018
-2.27K
Net shares
Net seller
$12.7K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
2.27K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−2.27K
Price / share
$5.60
Trade value
$12.68K
% of position
5.2%
3/14/2022
43.83K→41.57K
Total
Net shares
−2.27K
Net value
-$12.68K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/14/2022 | S · Sale | −2.27K | $5.60 | $12.68K | 5.2% | 43.83K | 41.57K |
| Total | −2.27K | -$12.68K | ||||||
Derivative Transactions0
No derivative transactions reported